EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Avid Bioservices's enterprise value is $971.0 Mil.
Avid Bioservices's Revenue for the trailing twelve months (TTM) ended in Oct. 2024 was $150.4 Mil. Therefore, Avid Bioservices's EV-to-Revenue for today is 6.45.
The historical rank and industry rank for Avid Bioservices's EV-to-Revenue or its related term are showing as below:
CDMO'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.37 Med: 5.54 Max: 20.63
Current: 6.45
During the past 13 years, the highest EV-to-Revenue of Avid Bioservices was 20.63. The lowest was 0.37. And the median was 5.54.
CDMO's EV-to-Revenue is not ranked
in the Biotechnology industry.
Industry Median: 7.16
vs CDMO: 6.45
As of today (2025-05-24), Avid Bioservices's stock price is $12.49.
Avid Bioservices's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2024 was $2.37. Therefore, Avid Bioservices's PS Ratio for today is 5.28.
Avid Bioservices EV-to-Revenue Historical Data
The historical data trend for Avid Bioservices's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Avid Bioservices's EV-to-Revenue
For the Biotechnology subindustry, Avid Bioservices's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avid Bioservices's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Avid Bioservices's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Avid Bioservices's EV-to-Revenue falls into.
Avid Bioservices's current Enterprise Value is $971.0 Mil.
Avid Bioservices's Revenue for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $150.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avid Bioservices's share price for today is $12.49.
Avid Bioservices's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.37.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avid Bioservices EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Avid Bioservices's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CDMO has been successfully added to your 